Variant report

Variant	nsv900388
Chromosome Location	chr13:66798923-66919700
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:387)
CpG islands
(count:61)
Chromatin interactive
region (count:8)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

(count:387 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr13:66886857-66887028	HepG2	liver:	n/a	n/a
2	ATF2	chr13:66798630-66799137	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF3	chr13:66886740-66887227	A549	lung:	n/a	n/a
4	BCL11A	chr13:66798709-66799125	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL11A	chr13:66798756-66799093	H1-hESC	embryonic stem cell:	n/a	n/a
6	BCL3	chr13:66886608-66887994	A549	lung:	n/a	n/a
7	BCL3	chr13:66886752-66887345	A549	lung:	n/a	n/a
8	BHLHE40	chr13:66917482-66917943	K562	blood:	n/a	n/a
9	BHLHE40	chr13:66902776-66902779	K562	blood:	n/a	n/a
10	BRCA1	chr13:66878245-66878246	Hela-S3	cervix:	n/a	n/a
11	CBX3	chr13:66861033-66861253	K562	blood:	n/a	n/a
12	CEBPB	chr13:66887481-66887890	A549	lung:	n/a	n/a
13	CEBPB	chr13:66798751-66799318	H1-hESC	embryonic stem cell:	n/a	n/a
14	CEBPB	chr13:66888568-66888896	A549	lung:	n/a	n/a
15	CEBPB	chr13:66808370-66808515	HepG2	liver:	n/a	chr13:66808482-66808493
16	CEBPB	chr13:66840059-66840240	HepG2	liver:	n/a	chr13:66840131-66840144 chr13:66840121-66840133
17	CEBPB	chr13:66872525-66872807	Hela-S3	cervix:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
18	CEBPB	chr13:66886928-66887166	A549	lung:	n/a	n/a
19	CEBPB	chr13:66886648-66888000	A549	lung:	n/a	n/a
20	CEBPB	chr13:66872539-66872758	H1-hESC	embryonic stem cell:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
21	CEBPB	chr13:66872470-66872807	IMR90	lung:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
22	CEBPB	chr13:66891929-66892183	HepG2	liver:	n/a	chr13:66892052-66892065 chr13:66892041-66892052
23	CEBPB	chr13:66808314-66808671	HepG2	liver:	n/a	chr13:66808482-66808493
24	CEBPB	chr13:66811924-66811972	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPB	chr13:66906331-66906484	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr13:66840058-66840316	IMR90	lung:	n/a	chr13:66840131-66840144 chr13:66840121-66840133
27	CEBPB	chr13:66898105-66898199	HepG2	liver:	n/a	chr13:66898111-66898122
28	CEBPB	chr13:66872481-66872820	HepG2	liver:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
29	CEBPB	chr13:66887551-66887864	HepG2	liver:	n/a	n/a
30	CEBPB	chr13:66888682-66888899	HepG2	liver:	n/a	n/a
31	CEBPB	chr13:66887553-66887871	IMR90	lung:	n/a	n/a
32	CEBPB	chr13:66886797-66887222	A549	lung:	n/a	n/a
33	CEBPB	chr13:66872466-66872822	A549	lung:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
34	CEBPB	chr13:66887496-66887884	A549	lung:	n/a	n/a
35	CEBPB	chr13:66872489-66872826	K562	blood:	n/a	chr13:66872645-66872656 chr13:66872626-66872637
36	CEBPD	chr13:66872704-66873142	K562	blood:	n/a	n/a
37	CHD2	chr13:66798730-66799172	H1-hESC	embryonic stem cell:	n/a	n/a
38	CHD2	chr13:66898349-66898352	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr13:66886531-66886751	A549	lung:	n/a	n/a
40	CREB1	chr13:66887670-66887940	A549	lung:	n/a	n/a
41	CREB1	chr13:66887558-66887926	A549	lung:	n/a	n/a
42	CTCF	chr13:66839620-66839770	HRE	kidney:	n/a	n/a
43	CTCF	chr13:66811840-66811990	RPTEC	kidney:	n/a	n/a
44	CTCF	chr13:66839540-66839690	HAc	cerebellar:	n/a	n/a
45	CTCF	chr13:66839520-66839670	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr13:66889260-66889410	GM12872	blood:	n/a	n/a
47	CTCF	chr13:66845240-66845390	AG09309	skin:	n/a	n/a
48	CTCF	chr13:66801778-66801801	LNCaP	prostate:	n/a	n/a
49	CTCF	chr13:66908162-66908197	Lung_OC	lung:	n/a	n/a
50	CTCF	chr13:66908200-66908204	Lung_OC	lung:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:66878738-66878788	ovcar-3	ovarian:	n/a
2	chr13:66878738-66878788	GM06990	blood:	n/a
3	chr13:66878738-66878788	Hepatocyte	liver:	n/a
4	chr13:66878738-66878788	PFSK-1	brain:	n/a
5	chr13:66878738-66878788	SK-N-MC	brain:	n/a
6	chr13:66878738-66878788	U87	brain:	n/a
7	chr13:66878738-66878788	Hela-S3	cervix:	n/a
8	chr13:66878738-66878788	H1-hESC	embryonic stem cell:	embryo
9	chr13:66878738-66878788	ProgFib	skin:	n/a
10	chr13:66878738-66878788	AG04450	lung:	fetal
11	chr13:66878738-66878788	NH-A	brain:	n/a
12	chr13:66878738-66878788	HNPCEpiC	eye:	n/a
13	chr13:66878738-66878788	HAEpiC	amniotic membrane:	n/a
14	chr13:66878738-66878788	PANC-1	pancreas:	n/a
15	chr13:66878738-66878788	NB4	blood:	n/a
16	chr13:66878738-66878788	BE2_C	brain:	n/a
17	chr13:66878738-66878788	BJ	skin:	n/a
18	chr13:66878738-66878788	HCPEpiC	choroid plexus:	n/a
19	chr13:66878738-66878788	HRPEpiC	eye:	n/a
20	chr13:66878738-66878788	Jurkat	blood:	n/a
21	chr13:66878738-66878788	A549	lung:	n/a
22	chr13:66878738-66878788	HIPEpiC	eye:	n/a
23	chr13:66878738-66878788	HEK293	kidney:	embryo
24	chr13:66878738-66878788	GM12891	blood:	n/a
25	chr13:66878738-66878788	MCF-7	breast:	n/a
26	chr13:66878738-66878788	Caco-2	colon:	n/a
27	chr13:66878738-66878788	NHDF-neo	bronchial:	n/a
28	chr13:66878738-66878788	AG10803	skin:	n/a
29	chr13:66878738-66878788	GM12892	blood:	n/a
30	chr13:66878738-66878788	AG09309	skin:	n/a
31	chr13:66878738-66878788	SK-N-SH_RA	brain:	n/a
32	chr13:66878738-66878788	HepG2	liver:	n/a
33	chr13:66878738-66878788	HPAEpiC	pulmonary alveolar:	n/a
34	chr13:66878738-66878788	MCF10A-Er-Src	breast:	n/a
35	chr13:66878738-66878788	SK-N-SH	brain:	n/a
36	chr13:66878738-66878788	HRE	kidney:	n/a
37	chr13:66878738-66878788	HCF	heart:	n/a
38	chr13:66878738-66878788	HMEC	breast:	n/a
39	chr13:66878738-66878788	GM12878	blood:	n/a
40	chr13:66878738-66878788	HEEpiC	esophagus:	n/a
41	chr13:66878738-66878788	NT2-D1	testis:	n/a
42	chr13:66878738-66878788	RPTEC	kidney:	n/a
43	chr13:66878738-66878788	T-47D	breast:	n/a
44	chr13:66878738-66878788	K562	blood:	n/a
45	chr13:66878738-66878788	GM19239	blood:	n/a
46	chr13:66878738-66878788	AG09319	gingival:	n/a
47	chr13:66878738-66878788	ECC-1	luminal epithelium:	n/a
48	chr13:66878738-66878788	SKMC	muscle:	n/a
49	chr13:66878738-66878788	AG04449	skin:	fetal
50	chr13:66878738-66878788	HRCEpiC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:66824109..66824810-chr16:71735977..71736631,2	MCF-7	breast:
2	chr13:66918574..66921439-chr13:66945401..66948264,2	MCF-7	breast:
3	chr13:66909684..66911530-chr13:66916300..66919201,2	K562	blood:
4	chr13:66901663..66903255-chr13:66906195..66907818,2	K562	blood:
5	chr13:66879908..66881972-chr13:66902872..66904425,2	K562	blood:
6	chr13:66901663..66903255-chr13:66906195..66907818,2	K562	blood:
7	chr13:66879908..66881972-chr13:66902872..66904425,2	K562	blood:
8	chr13:66909684..66911530-chr13:66916300..66919201,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL445989.1-26	chr13:66843129-66844590	NONHSAT034207
2	lnc-AL445989.1-26	chr13:66846998-66847098	NONHSAT034208
3	lnc-AL445989.1-26	chr13:66851684-66852109	NONHSAT034208
4	lnc-AL445989.1-26	chr13:66844520-66844603	NONHSAT034208
5	lnc-AL445989.1-13	chr13:66878003-66878146	ENSG00000234527.1
6	lnc-AL445989.1-13	chr13:66897306-66897693	ENSG00000234527.1
7	lnc-PCDH9-1	chr13:66805874-66806206	ENSG00000250631

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	PCDH9	hsa-miR-155-5p	chr13:66878327-66878320
2	PCDH9	hsa-miR-155-5p	chr13:66878321-66878343
3	PCDH9	hsa-miR-155-5p	chr13:66877756-66877779

Variant related genes	Relation type
TRIM60P19	TF binding region
PCDH9-AS1	TF binding region
TRIM60P19	CpG island
PCDH9-AS1	CpG island

Extended variants
information (count: 2845 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:2845 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11618305	chr13:66798923-66798924	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs113305403	chr13:66798982-66798983	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs184668013	chr13:66799004-66799005	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs552769173	chr13:66799019-66799020	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs541027882	chr13:66799025-66799026	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs572652689	chr13:66799044-66799045	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs545107523	chr13:66799053-66799054	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs77637194	chr13:66799124-66799125	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs139070647	chr13:66799138-66799139	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs189147795	chr13:66799169-66799170	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs9540688	chr13:66799170-66799171	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs546348775	chr13:66799174-66799175	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs113354416	chr13:66799175-66799176	Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs530438447	chr13:66799200-66799201	Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs566969850	chr13:66799241-66799242	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs547287650	chr13:66799250-66799251	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs181904448	chr13:66799273-66799274	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs207473940	chr13:66799286-66799287	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs74094858	chr13:66799325-66799326	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs532714776	chr13:66799336-66799337	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs74864887	chr13:66799354-66799355	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs34581793	chr13:66799366-66799367	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs149912215	chr13:66799379-66799380	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs536678590	chr13:66799407-66799408	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs556929992	chr13:66799422-66799423	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs567120096	chr13:66799442-66799443	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs144986182	chr13:66799445-66799446	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs552805882	chr13:66799454-66799455	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs572740092	chr13:66799528-66799529	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs377168411	chr13:66799532-66799533	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs185736350	chr13:66799583-66799584	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs558653416	chr13:66799589-66799590	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs575678726	chr13:66799642-66799643	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs550479417	chr13:66799720-66799721	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs77922479	chr13:66799804-66799805	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs534439821	chr13:66799886-66799887	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs561357102	chr13:66799906-66799907	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs574697908	chr13:66799925-66799926	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs550049430	chr13:66799927-66799928	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs190590776	chr13:66799958-66799959	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs532804732	chr13:66799967-66799968	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs142186196	chr13:66799981-66799982	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs201103308	chr13:66799992-66799993	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs199988474	chr13:66799993-66799994	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs80246897	chr13:66799994-66799995	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs67987457	chr13:66799995-66799996	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs200479373	chr13:66799996-66799997	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs115517083	chr13:66799998-66799999	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs78738476	chr13:66799999-66800000	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs550356961	chr13:66800034-66800035	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Prostate cancer	16461572	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:389 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:66790000-66800400	Enhancers	Dnd41	blood
2	chr13:66794800-66799400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr13:66797400-66800600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
4	chr13:66797600-66800600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
5	chr13:66797800-66799000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
6	chr13:66798000-66799000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr13:66798200-66799000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
8	chr13:66798200-66799600	Enhancers	Thymus	Thymus
9	chr13:66798200-66800000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr13:66798200-66800600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr13:66798400-66799400	Enhancers	Placenta Amnion	Placenta Amnion
12	chr13:66798400-66799600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr13:66798600-66799000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
14	chr13:66798600-66799800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr13:66798800-66799000	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr13:66798800-66799000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr13:66798800-66799600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr13:66798800-66799600	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr13:66798800-66799600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr13:66798800-66800200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr13:66798800-66800600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
22	chr13:66799000-66799200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
23	chr13:66799000-66799600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
24	chr13:66799000-66799800	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr13:66799200-66799400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
26	chr13:66799200-66799600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
27	chr13:66799200-66799600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
28	chr13:66799200-66800600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
29	chr13:66799400-66799800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr13:66799400-66800200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr13:66799600-66800000	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr13:66799600-66800200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
33	chr13:66799600-66800600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
34	chr13:66799800-66800600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
35	chr13:66800000-66800200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr13:66800000-66800200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
37	chr13:66800200-66800600	Active TSS	ES-WA7 Cell Line	embryonic stem cell
38	chr13:66800200-66800600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
39	chr13:66800200-66800600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
40	chr13:66801400-66801600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
41	chr13:66803000-66803200	Enhancers	HUES6 Cell Line	embryonic stem cell
42	chr13:66803600-66805000	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr13:66805000-66805800	Active TSS	ES-I3 Cell Line	embryonic stem cell
44	chr13:66805000-66805800	Active TSS	HUES6 Cell Line	embryonic stem cell
45	chr13:66805000-66806400	Active TSS	H9 Cell Line	embryonic stem cell
46	chr13:66805200-66805600	Active TSS	H1 Cell Line	embryonic stem cell
47	chr13:66805200-66805600	Active TSS	HUES64 Cell Line	embryonic stem cell
48	chr13:66805200-66805600	Active TSS	iPS-18 Cell Line	embryonic stem cell
49	chr13:66805200-66805600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr13:66805200-66805800	Active TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links